-
Collins Stewart Downgrades Morgan Stanley from Buy to Hold, Raises PT to $23
Wednesday, February 8, 2012 - 6:30am -
Collins Stewart Raises PT on BioMimetic Therapeutics from $4 to $7
Tuesday, February 7, 2012 - 9:34am -
Collins Stewart Reiterates Buy, $18 PT on Fabrinet
Wednesday, February 1, 2012 - 9:35am | 122Collins Stewart remains Buy-rated with an $18 price target on Fabrinet (NYSE: FN) as the company looks to rebound in the March quarter following recovery progress from Thai floods. Collins Stewart says, "We upgraded the shares back on 11/3, not due to expectations for the Dec. qtr, but from...
-
Collins Stewart Maintains Neutral, $180 Target on Amazon.com
Wednesday, February 1, 2012 - 9:31am | 141Collins Stewart reiterates its Neutral rating and $180 target price on Amazon.com (NASDAQ: AMZN) as a surprising 4Q miss and disappointing 1Q guide from the company does not materially impact investment thesis. Collins Stewart says, "Amazon reported a mixed 4Q, with revenues of $17.4B missing...
-
Collins Stewart Reiterates Neutral, $35 Target on Dolby
Wednesday, February 1, 2012 - 9:27am | 108Collins Stewart maintains its Neutral rating and $35 target price on Dolby (NYSE: DLB) as the company reports in-line results for its December quarter. Collins Stewart says, "DLB reports inline FQ1'12 (Dec) results and maintains its FY'12 (Sept) outlook, despite concerns of HDD shortages...
-
Collins Stewart Lowers PT on Amazon.com to $180
Wednesday, February 1, 2012 - 7:56am | 27Collins Stewart has lowered the price target on Amazon.com (NASDAQ: AMZN) from $190 to $180 and maintains its Neutral rating.
-
Collins Stewart on Baidu: Expect In-Line Quarter
Thursday, January 26, 2012 - 9:07am | 153Collins Stewart has published a research report on Baidu (NASDAQ: BIDU) ahead of the company's earnings report and says to expect in-line results. In the report, Collins Stewart writes, "We expect Baidu to report a 4Q that is in-line or a slight miss, compared to consensus revenue / PF EPS...
-
UPDATE: Collins Stewart Raises PT to $35 on Volterra Semiconductor, Maintains Buy
Tuesday, January 24, 2012 - 9:45am | 140Collins Stewart reiterates its Buy rating on Volterra Semiconductor (NASDAQ: VLTR) and raises its price target to $35 from $29 as the company provides in-line results and outlook and Romley begins to ramp. Collins Stewart says, "Our increased PT reflects better than expected EPS results and the...
-
Collins Stewart Reiterates Buy, $108 on VMware
Monday, January 23, 2012 - 11:02am | 143Collins Stewart maintains its Buy rating and $108 price target on VMware (NYSE: VMW) as it expects good results from the company following 4Q preview. Collins Stewart says, "We believe the company closed another strong quarter and with the shares trading down recently, in-line with the software...
-
Collins Stewart Reiterates Buy, $750 on Google
Friday, January 20, 2012 - 11:43am | 116Collins Stewart maintains its Buy rating and $750 target price on Google (NASDAQ: GOOG) as 4Q miss on CPC pressure does not affect investment thesis. Collins Stewart says, "Net revenues of $8.1B (up 28% Y/Y, up 8% Q/Q) were 3% lower than consensus of $8.4B, due to adverse FX impact of $239M Q/Q...
-
Collins Stewart Maintains Neutral, $36 PT on Verizon
Friday, January 20, 2012 - 9:53am | 91Collins Stewart reiterates its Neutral rating and $36 target price on Verizon (NYSE: VZ) as it adjusts the company's estimates based on its iPhone strength. Collins Stewart says, "We are adjusting our 4Q11 and FY2011 EPS estimates following the conversation at an investor conference earlier this...
-
Collins Stewart Reiterates Buy, $9 Target on Flextronics
Friday, January 20, 2012 - 9:47am | 148Collins Stewart maintains its Buy rating and $9 target price on Flextronics (NASDAQ: FLEX) as the company shifts away from some High Velocity works. Collins Stewart says, "Flextronics reported Dec qtr revenue of $7.5B which was at the high end of prior lowered guidance. EPS of $0.18 was at the...
-
Collins Stewart Maintains Buy, $33 Target on Microsoft
Friday, January 20, 2012 - 9:43am | 136Collins Stewart reiterates its Buy rating and $33 target price on Microsoft (NASDAQ: MSFT) as the company's focus returns to product launches. Collins Stewart says, "MSFT's commentary last week that PC sales in the December quarter were worse than expected raised investor concerns about a...
-
UPDATE: Collins Stewart Raises PT to $515 on Intuitive Surgical, Reiterates Buy
Friday, January 20, 2012 - 9:39am | 124Collins Stewart maintains its Buy rating on Intuitive Surgical (NASDAQ: ISRG) and increases its price target to $515 from $475 as they believe shares will move higher after taking a temporary breather. Collins Stewart says, "With ISRG's stock price hovering around its all-time high, we are not...
-
Collins Stewart Reiterates Buy rating and $210 Target on IBM
Friday, January 20, 2012 - 9:33am | 116Collins Steward maintains its Buy rating and $210 target price on IBM (NYSE: IBM) as the company maintains its consistency in results. Colins Stewart says, "With moderated expectations, IBM's 4Q11 results of $29.5B, up 2% y/y vs. consensus of $29.7B with EPS of $4.71 vs. the Street's $4.62 were...